CHEMORADIOTHERAPY
Clinical trials for CHEMORADIOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new CHEMORADIOTHERAPY trials appear
Sign up with your email to follow new studies for CHEMORADIOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for inoperable esophageal cancer: Triple-Threat treatment trial
Disease control Recruiting nowThis study is testing a new combination treatment for people with advanced esophageal cancer that cannot be removed by surgery. The treatment involves a targeted drug (surufatinib), immunotherapy (toripalimab), chemotherapy, and radiation. The goal is to see if this combination c…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Four-Pronged attack on aggressive lung cancer enters human testing
Disease control Recruiting nowThis study is testing a new combination treatment for people with limited-stage small cell lung cancer, a fast-growing type of lung cancer. The treatment combines standard chemotherapy and radiation with two newer drugs: toripalimab (an immunotherapy) and surufatinib (a targeted …
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scientists test Triple-Threat therapy to wipe out rectal tumors
Disease control Recruiting nowThis study is testing a new combination of treatments for people with locally advanced rectal cancer. The goal is to see if adding an immunotherapy drug to a standard mix of radiation, chemotherapy, and a targeted drug can better shrink tumors before surgery. Researchers will com…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
New shot aims to shield cancer patients from dangerous chemo side effect
Disease control Recruiting nowThis study is testing if a drug called mecapegfilgrastim can safely prevent a serious side effect of combined chemotherapy and radiation for chest cancers. The side effect, called myelosuppression, causes dangerously low white blood cell counts, increasing infection risk. Researc…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Affiliated Hospital of Nantong University • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Major audit reveals gaps in cervical cancer care across india
Knowledge-focused Recruiting nowThis study is checking how closely cancer treatment centers in India follow the national standard guidelines for treating cervical cancer with radiation and chemotherapy. Researchers will collect anonymous treatment data from over 600 patients across many hospitals to see where g…
Matched conditions: CHEMORADIOTHERAPY
Sponsor: Tata Memorial Hospital • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:58 UTC